Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis
Author:
Affiliation:
1. Johns Hopkins University, Baltimore, Maryland, USA
2. Bristol Myers Squibb, San Diego, California, USA
3. TB Alliance, New York, New York, USA
4. Bristol Myers Squibb, Global Health, San Diego, California, USA
Abstract
Funder
Bill and Melinda Gates Foundation
Bundesministerium für Bildung und Forschung
Department of Foreign Affairs and Trade, Australian Government
Foreign and Commonwealth Office
Irish Aid
Ministerie van Buitenlandse Zaken
United States Agency for International Development
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.00253-21
Reference32 articles.
1. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
2. Advancing host-directed therapy for tuberculosis
3. Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
4. Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
5. Autophagy modulation as a potential therapeutic target for diverse diseases
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of Drug Sensitisers to Improve Therapeutic Index in Cancer;Pharmaceutics;2024-07-11
2. Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis;Antimicrobial Agents and Chemotherapy;2024-04-03
3. Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection;Cells;2023-11-18
4. Identifying autophagy-related genes as potential targets for immunotherapy in tuberculosis;International Immunopharmacology;2023-05
5. Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection;Frontiers in Immunology;2022-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3